Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Cost of eradication treatment may have been overestimated.
Waugh
N R
NR
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004415:Dyspepsia / Q000191:economics / Q000382:microbiology / Q000628:therapy; D016481:Helicobacter Infections / Q000517:prevention & control*; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000191:economics*; D006801:Humans; D008403:Mass Screening / Q000191:economics
D006635:Histamine H2 Antagonists